CADTH | Evidence Driven
CADTH | Evidence Driven

International Normalized Point of Care Testing for Patients on Anticoagulant Therapies: Clinical Utility and Cost-Effectiveness

Details

Files
Project Status:
Completed
Project Line:
Reference List
Project Sub Line:
Summary of Abstracts
Project Number:
RB1466-000

Question

  1.  What is the clinical utility of international normalized ratio point of care testing for patients on anticoagulation therapies?
  2. What is the cost-effectiveness of international normalized ratio point of care testing for patients on anticoagulation therapies?

Key Message

Nine non-randomized studies were identified regarding the clinical utility of international normalized ratio point of care testing for patients on anticoagulation therapies. No relevant economic evaluations were identified regarding the cost-effectiveness of international normalized ratio point of care testing for patients on anticoagulation therapies.

Files

International Normalized Point of Care Testing for Patients on Anticoagulant Therapies: Clinical Utility and Cost-Effectiveness Rapid Response April 22, 2020 View PDF

Related Content

Last Updated : April 27, 2020